Net Cash Provided by (Used in) Investing Activities of Eloxx Pharmaceuticals, Inc. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary: Eloxx Pharmaceuticals, Inc. annual and quarterly Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 30 Jun 2010 to 31 Dec 2025.
Eloxx Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2023 was $11,000.
Eloxx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2025 was $1,000, a 97% decline from 2024.
Eloxx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $38,000, a 88% decline from 2023.
Eloxx Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $309,000.
Source SEC data: View on sec.gov

Net Cash Provided by (Used in) Investing Activities, Annual (USD)

Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)

Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)

Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)

Eloxx Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$1,000	-$37,000	-97%	01 Jan 2025	31 Dec 2025	10-K	17 Mar 2026	2025	FY
2024	$38,000	-$271,000	-88%	01 Jan 2024	31 Dec 2024	10-K	17 Mar 2026	2025	FY
2023	$309,000	+$375,000		01 Jan 2023	31 Dec 2023	10-K	17 Mar 2026	2025	FY
2022	$66,000	-$2,122,000	-103%	01 Jan 2022	31 Dec 2022	10-K	31 Mar 2023	2022	FY
2021	$2,056,000	-$31,736,000	-94%	01 Jan 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY
2020	$33,792,000	+$67,316,000		01 Jan 2020	31 Dec 2020	10-K	30 Mar 2022	2021	FY
2019	$33,524,000	-$33,207,000	-10475%	01 Jan 2019	31 Dec 2019	10-K	30 Mar 2022	2021	FY
2018	$317,000	-$203,000	-178%	01 Jan 2018	31 Dec 2018	10-K	12 Mar 2021	2020	FY
2017	$114,000	-$78,000	-217%	01 Jan 2017	31 Dec 2017	10-K	06 Mar 2020	2019	FY
2016	$36,000	-$1,522,000	-102%	01 Jan 2016	31 Dec 2016	10-K	14 Mar 2019	2018	FY
2015	$1,486,000	+$839,064	+130%	01 Jan 2015	31 Dec 2015	10-K	16 Mar 2018	2017	FY
2014	$646,936	+$1,175,978		01 Jul 2013	30 Jun 2014	10-K	29 Sep 2014	2014	FY
2013	$529,042	-$78,546	-17%	01 Jul 2012	30 Jun 2013	10-K	29 Sep 2014	2014	FY
2012	$450,496	+$235,929	+34%	01 Jul 2011	30 Jun 2012	10-K	29 Sep 2014	2014	FY
2011	$686,425	-$927,394	-385%	01 Jul 2010	30 Jun 2011	10-K	11 Sep 2013	2013	FY
2010	$240,969			01 Jul 2009	30 Jun 2010	10-K/A	26 Oct 2012	2012	FY

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2023	$11,000	+$22,000		01 Jan 2023	31 Mar 2023	10-Q	12 May 2023	2023	Q1
Q1 2022	$11,000			01 Jan 2022	31 Mar 2022	10-Q	12 May 2023	2023	Q1
Q1 2020	$15,789,000	+$24,731,000		01 Jan 2020	31 Mar 2020	10-Q	07 May 2021	2021	Q1
Q1 2019	$8,942,000	-$8,885,000	-15588%	01 Jan 2019	31 Mar 2019	10-Q	08 May 2020	2020	Q1
Q1 2018	$57,000	+$39,000	+41%	01 Jan 2018	31 Mar 2018	10-Q	09 May 2019	2019	Q1
Q3 2017	$0	-$50,000	-100%	01 Jul 2017	30 Sep 2017	10-Q	14 Nov 2017	2018	Q1
Q1 2017	$96,000			01 Jan 2017	31 Mar 2017	10-Q	10 May 2018	2018	Q1
Q3 2016	$50,000			01 Jul 2016	30 Sep 2016	10-Q	14 Nov 2017	2018	Q1
Q3 2014	$334,804	-$191,861	-134%	01 Jul 2014	30 Sep 2014	10-Q	14 Nov 2014	2015	Q1
Q3 2013	$142,943	+$4,055	+2.8%	01 Jul 2013	30 Sep 2013	10-Q	14 Nov 2014	2015	Q1
Q3 2012	$146,998	-$18,159	-14%	01 Jul 2012	30 Sep 2012	10-Q	14 Nov 2013	2014	Q1
Q3 2011	$128,839	+$843	+0.65%	01 Jul 2011	30 Sep 2011	10-Q	14 Nov 2012	2013	Q1
Q3 2010	$129,682			01 Jul 2010	30 Sep 2010	10-Q	14 Nov 2011	2012	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.